超适应症-话题@MedSci

#超适应症#

3篇内容 | 467人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2082842, encodeId=15532082842fb, content=<a href='/topic/show?id=1daa9293300' target=_blank style='color:#2F92EE;'>#超适应症#</a>, objectTitle=“假药门”法律争议焦点科普之——超适应症用药违法吗？, objectType=article, longId=181518, objectId=f0cd1815184a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0cd1815184a, replyNumber=0, likeNumber=31, createdTime=2020-05-07, rootId=0, userName=12498bd5m16暂无昵称, userId=198d2500149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0cd1815184a, moduleTitle=“假药门”法律争议焦点科普之——超适应症用药违法吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0cd1815184a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082841, encodeId=c2af2082841a0, content=<a href='/topic/show?id=1daa9293300' target=_blank style='color:#2F92EE;'>#超适应症#</a>, objectTitle=Nature：癌症患者或能从“超适应症”药物中获益, objectType=article, longId=180428, objectId=37fe1804288a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37fe1804288a, replyNumber=0, likeNumber=32, createdTime=2020-07-24, rootId=0, userName=12498bd5m16暂无昵称, userId=198d2500149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37fe1804288a, moduleTitle=Nature：癌症患者或能从“超适应症”药物中获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37fe1804288a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082840, encodeId=9392208284049, content=<a href='/topic/show?id=1daa9293300' target=_blank style='color:#2F92EE;'>#超适应症#</a>, objectTitle=PD-1正在触碰超适应症的红线，违规用药但治疗有效的局面如何破, objectType=article, longId=165138, objectId=a4f3165138b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4f3165138b0, replyNumber=0, likeNumber=0, createdTime=2019-07-31, rootId=0, userName=12498bd5m16暂无昵称, userId=198d2500149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4f3165138b0, moduleTitle=PD-1正在触碰超适应症的红线，违规用药但治疗有效的局面如何破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4f3165138b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

超适应症

2020-05-29

12498bd5m16暂无昵称 (审核中...)

前往app查看评论内容

#超适应症#

“假药门”法律争议焦点科普之——超适应症用药违法吗？

2020-05-07

12498bd5m16暂无昵称 (审核中...)

前往app查看评论内容

#超适应症#

Nature：癌症患者或能从“超适应症”药物中获益

2020-07-24

12498bd5m16暂无昵称 (审核中...)

前往app查看评论内容

#超适应症#

PD-1正在触碰超适应症的红线，违规用药但治疗有效的局面如何破

2019-07-31

科室
- - 订阅+
  - 更多科室
工具
服务